Key statistics
As of last trade Novozymes A/S (0Q4U:LSE) traded at 386.10, 4.75% above its 52-week low of 368.60, set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 390.10 |
|---|---|
| High | 386.10 |
| Low | 386.10 |
| Bid | 381.00 |
| Offer | 396.90 |
| Previous close | 386.10 |
| Average volume | 80.73k |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.25m |
| P/E (TTM) | -- |
| Market cap | 159.88bn DKK |
| EPS (TTM) | -- |
| Annual div (ADY) | 4.35 DKK |
|---|---|
| Annual div yield (ADY) | 1.13% |
| Div ex-date | Aug 22 2025 |
| Div pay-date | Aug 27 2025 |
Data delayed at least 20 minutes, as of Feb 11 2026 13:48 GMT.
More ▼
- Trading by management and close relations of management
- Trading by management and close relations of management
- Major shareholder announcement
- Novonesis delivered 8% organic sales growth in the first nine months of 2025
- 8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.
- Trading by management and close relations of management
- Noma and Novonesis partner to scale deliciousness
- Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters
- Major shareholder announcement
- Trading by management and close relations of management
More ▼
